Literature DB >> 2420800

On the recognition of helical RNA by cobra venom V1 nuclease.

H B Lowman, D E Draper.   

Abstract

The V1 nuclease from cobra venom preferentially hydrolyzes double helical RNA and has been used extensively for detecting RNA secondary structure. To increase the utility of this enzyme as an RNA structure probe, we have investigated its properties and substrate specificity, using assays for polynucleotide hydrolysis based on fluorescent polynucleotide derivatives. Enzymatic activity requires both Na+ and Mg2+, with optima at 100 and 0.3 mM, respectively. From the sharp decrease in enzyme activity above 100 mM Na+ we estimate that 3-4 ionic interactions between the protein and polynucleotide phosphates take place. Analysis of products remaining after extensive V1 digestion also shows that the minimum size substrate is 4-6 nucleotides long. Helical RNAs and DNAs have Michaelis constants a factor of 3-10 times lower than most single-stranded RNAs. However, poly(epsilon A) has a Michaelis constant equal to the best synthetic double helices tested and is hydrolyzed at a rate comparable to helical RNA. The major V1 cutting sites in yeast tRNAPhe have Michaelis constants lower than any synthetic polymers. These data suggest that V1 nuclease recognizes any 4-6-nucleotide segment of polynucleotide backbone with an approximately helical conformation, but does not require that the bases be paired in a helix. A few single-stranded V1 cleavage sites are known in tRNA and rRNA, and their structures are consistent with the suggested V1 recognition site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420800

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Identification of the minimal essential RNA sequences responsible for site-specific targeting of the Leishmania RNA virus 1-4 capsid endoribonuclease.

Authors:  Y T Ro; J L Patterson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A phylogenetically conserved hairpin-type 3' untranslated region pseudoknot functions in coronavirus RNA replication.

Authors:  G D Williams; R Y Chang; D A Brian
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Structure of a regulatory 3' untranslated region from Trypanosoma brucei.

Authors:  M Drozdz; C Clayton
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

4.  Molecular recognition of pyr mRNA by the Bacillus subtilis attenuation regulatory protein PyrR.

Authors:  E R Bonner; J N D'Elia; B K Billips; R L Switzer
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

5.  A La protein requirement for efficient pre-tRNA folding.

Authors:  Ghadiyaram Chakshusmathi; Sang Do Kim; Douglas A Rubinson; Sandra L Wolin
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  An additional long-range interaction in human U1 snRNA.

Authors:  C Sturchler; P Carbon; A Krol
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

7.  Secondary structure as a functional feature in the downstream region of mammalian polyadenylation signals.

Authors:  Chunxiao Wu; James C Alwine
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Secondary structure of two regions in expansion segments ES3 and ES6 with the potential of forming a tertiary interaction in eukaryotic 40S ribosomal subunits.

Authors:  Gunnar Alkemar; Odd Nygård
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

9.  Structural analysis of the 5' domain of the HeLa 18S ribosomal RNA by chemical and enzymatic probing.

Authors:  V Mandiyan; M Boublik
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

10.  An RNA stem-loop within the bovine coronavirus nsp1 coding region is a cis-acting element in defective interfering RNA replication.

Authors:  Cary G Brown; Kimberley S Nixon; Savithra D Senanayake; David A Brian
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.